Ishmael D. Aziati, PhD

Ishmael D. Aziati, PhD

Instructor of Medicine

Dr Aziati specializes in the use of integrated approaches to control and prevent emerging vector-borne and zoonotic viral diseases, with a special focus on pathogen surveillance and developing therapeutic interventions.

Megan Tierney Baldridge, MD, PhD

Megan Tierney Baldridge, MD, PhD

Associate Professor, Departments of Medicine and Molecular Microbiology

Dr. Baldridge studies the complicated interplay among three important factors: commensal microbes, the host immune system, and viral and bacterial pathogens.

Jacco Boon, PhD

Jacco Boon, PhD

Professor of Medicine, Molecular Microbiology and Pathology and Immunology

Dr. Boon He specializes in basic research on RNA viruses, with a special focus on emerging virus such as influenza virus, Bourbon virus and SARS-CoV-2.

Philip J. Budge, MD, PhD

Philip J. Budge, MD, PhD

Associate Professor of Medicine

Dr. Budge specializes in translational, public health-related research, with a special focus on filarial infections—insect-borne threadlike parasitic worms that cause lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), and loiasis (African eye worm).

Matthew Cain, PhD

Matthew Cain, PhD

Assistant Professor of Medicine

Brett Case, PhD

Brett Case, PhD

Instructor in Medicine

Dr. Case's primary research interests include vaccine design, generation of broadly cross-reactive immune responses, mucosal immunity, viral immunology, and emerging pathogens.

Pallavi Chandra, PhD

Pallavi Chandra, PhD

Instructor in Medicine

Dr. Chandra specializes in Mycobacterium tuberculosis pathogenesis, with a special focus on immunometabolism. In recent work, she characterized a novel relationship between macrophage fatty acid metabolism and antimycobacterial immunity.

Zhenlu Chong, PhD

Zhenlu Chong, PhD

Instructor in Medicine

Dr. Chong specializes in innate immunology and infectious diseases, with a special focus on how innate immunity responds to flavivirus infection. He is also very interested in identifying host factors of flaviviruses including West Nile virus, Dengue virus, Zika virus, etc. by using CRISPR screening.

Pritesh Desai, PhD

Pritesh Desai, PhD

Instructor in Medicine

Dr. Desai concentration is immunology and microbiology, and virology.

Michael S. Diamond, MD, PhD

Michael S. Diamond, MD, PhD

The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology

Michael Diamond, MD, PhD is the leader of a basic and translational research laboratory studying the interface between viral pathogenesis and host immunity. His laboratory focuses on emerging RNA viruses including flaviviruses, alphaviruses, and coronaviruses.

Erik R. Dubberke, MD, MSPH

Erik R. Dubberke, MD, MSPH

Professor of Medicine

Dr. Dubberke specializes in clinical and translational infectious diseases, with a focus on transplant infectious diseases, hospital epidemiology, and Clostridioides difficile infection (CDI).

Peter U. Fischer, PhD

Peter U. Fischer, PhD

Professor of Medicine

Dr. Fischer specializes in basic and translational sciences to support the control and elimination of neglected tropical diseases, with a special focus on helminths.

James M. Fleckenstein, MD

James M. Fleckenstein, MD

Professor, Departments of Medicine, Molecular Microbiology

Dr. Fleckenstein’s lab focuses on the identification and molecular characterization of novel ETEC virulence factors that could serve as targets for vaccine development. Studies in the lab use a variety of molecular techniques and in vitro and in vivo models to elucidate the role of these novel virulence factors in several key steps essential in the pathogenesis of these organisms: bacterial adhesion, intestinal colonization, and finally toxin delivery.

Daniel E. Goldberg, MD, PhD

Daniel E. Goldberg, MD, PhD

David M. and Paula L. Kipnis Distinguished Professor, Departments of Medicine and Molecular Microbiology

Dr. Goldberg does basic research on the biology of malaria and identification of drug targets. Parasites have evolved many clever ways to infect their hosts and develop within them. Researching these processes at a molecular level should lead to treatment or prevention of parasitic infections that afflict most of humanity. His laboratory currently has 4 graduate students, 2 postdocs, one pediatric ID fellow, one technician and a research associate professor. Dr. Goldberg directs the Infectious Diseases/Basic Microbial Mechanisms T32 training grant.

Jeffrey P. Henderson, MD, PhD

Jeffrey P. Henderson, MD, PhD

Professor of Medicine and Molecular Microbiology

Dr. Henderson specializes in infection pathogenesis, with a special focus on urinary tract infections and identifying how special bacterial adaptations increase pathogenic potential in patients.

Eva Istvan, PhD

Eva Istvan, PhD

Associate Professor of Medicine

Dr. Istvan specializes in the biochemistry of Plasmodium falciparum, the most deadly malaria parasites of humans.

Javan Kisaka, PhD

Javan Kisaka, PhD

Instructor in Medicine

Dr. Kisaka specializes in cell, structural and molecular microbiology and currently works in the Kyei Lab.

Dimitri Kotov, PhD

Dimitri Kotov, PhD

Assistant Professor of Medicine

Dr. Kotov's research expands on the theme of innate immune exacerbation of tuberculosis disease by continuing to study the role of plasmacytoid dendritic cells during infection and identifying additional mechanisms by which neutrophils and macrophages inhibit product responses against Mtb.

Jennie H. Kwon, DO, MSCI

Jennie H. Kwon, DO, MSCI

Associate Professor of Medicine, Section Director, Healthcare Epidemiology & Antimicrobial Stewardship

Dr. Kwon specializes in clinical and translational research with a focus on antimicrobial resistance and infection prevention.

George B. Kyei, MBChB, PhD

George B. Kyei, MBChB, PhD

Associate Professor, Departments of Medicine and Molecular Microbiology

Dr. Kyei specializes in HIV basic and translational research, with a special focus on viral latency and reactivation specifically:  (i) characterization of factors that control HIV replication in macrophages, dendritic and resting T cells and (ii) identification of cellular factors and small molecules required for HIV reactivation in latently infected cell and (iii) perspectives of HIV patients on HIV cure.